Genome-wide analysis of DNA methylation identifies S100A13 as an epigenetic biomarker in individuals with chronic (≥ 30 years) type 2 diabetes without diabetic retinopathy

Abstract excerpt

BACKGROUND: This study aimed to determine the epigenetic biomarkers of diabetic retinopathy (DR) in subjects with type 2 diabetes mellitus (T2DM). This retrospective study is based on the Shanghai Xinjing community prevention and treatment administrative system of chronic diseases. The subjects enrolled herein were T2DM patients who had undergone long-term follow-up evaluation in the system. Two consecutive...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Advanced Glycation End Products research
• Share to Retinal Diseases and Treatments
• Share to S100 Proteins and Annexins